Product Description
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Chile | Colombia | Indonesia | Turkey
Approved Indications: None
Known Adverse Events: None
Company: Horizon Science
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| EDA-YL-EBRAR-TOROS-001 | N/A |
Active, not recruiting |
Tobacco Use Disorder|Obesity|Alcoholic Intoxication |
2024-02-01 |
|
| ACTRN12615001263583 | N/A |
Recruiting |
Obesity |
2015-12-21 |
|
| ACTRN12614001141639 | N/A |
Completed |
Healthy Volunteers |
2012-10-01 |
|
| NCT00467350 | N/A |
Terminated |
Constipation |
2009-05-01 |